Researchers followed 180 patients treated with phrenic nerve reconstruction. 89% of these patients reported an overall improvement in breathing function.
The new medication targets a protein called apolipoprotein C-III. By neutralizing this protein, it effectively speeds up the breakdown of triglycerides.